|
Independent group says new Glaxo asthma drug far too expensive
Pharmacy Today, American Pharmacists Association, pharmacist.com The nonprofit analyzed the once-monthly injectable drug for severe asthma, finding that it should be priced at $7,800 to $12,000 a year, compared with the current list price of $32,500 a year. While the drug significantly reduces asthma attacks and … |
View full post on asthma – Google News